FI822671L - Aminoglykosidderivat, foerfaranden foer framstaellning av dem, farmaceutiska kompositioner innehaollande dem samt anvaendning av saodana derivat som laekemedel - Google Patents

Aminoglykosidderivat, foerfaranden foer framstaellning av dem, farmaceutiska kompositioner innehaollande dem samt anvaendning av saodana derivat som laekemedel

Info

Publication number
FI822671L
FI822671L FI822671A FI822671A FI822671L FI 822671 L FI822671 L FI 822671L FI 822671 A FI822671 A FI 822671A FI 822671 A FI822671 A FI 822671A FI 822671 L FI822671 L FI 822671L
Authority
FI
Finland
Prior art keywords
pharmaceutical composition
dem
framstaellning
hydroxy
innehaollande
Prior art date
Application number
FI822671A
Other languages
English (en)
Finnish (fi)
Other versions
FI822671A0 (fi
Inventor
Hans Loibner
Wolfgang Streicher
Peter Stytz
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI822671A0 publication Critical patent/FI822671A0/fi
Publication of FI822671L publication Critical patent/FI822671L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/224—Cyclohexane rings substituted by at least two nitrogen atoms with only one saccharide radical directly attached to the cyclohexyl radical, e.g. destomycin, fortimicin, neamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI822671A 1981-08-07 1982-07-30 Aminoglykosidderivat, foerfaranden foer framstaellning av dem, farmaceutiska kompositioner innehaollande dem samt anvaendning av saodana derivat som laekemedel FI822671L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH510781 1981-08-07

Publications (2)

Publication Number Publication Date
FI822671A0 FI822671A0 (fi) 1982-07-30
FI822671L true FI822671L (fi) 1983-02-08

Family

ID=4288039

Family Applications (1)

Application Number Title Priority Date Filing Date
FI822671A FI822671L (fi) 1981-08-07 1982-07-30 Aminoglykosidderivat, foerfaranden foer framstaellning av dem, farmaceutiska kompositioner innehaollande dem samt anvaendning av saodana derivat som laekemedel

Country Status (13)

Country Link
US (1) US4503046A (ja)
EP (1) EP0072351B1 (ja)
JP (1) JPS5838299A (ja)
AT (1) ATE14437T1 (ja)
AU (1) AU8678682A (ja)
CA (1) CA1196629A (ja)
DE (1) DE3264906D1 (ja)
DK (1) DK351982A (ja)
ES (1) ES514767A0 (ja)
FI (1) FI822671L (ja)
IL (1) IL66473A0 (ja)
PT (1) PT75385B (ja)
ZA (1) ZA825730B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3334383A1 (de) * 1982-09-30 1984-04-05 Sandoz-Patent-GmbH, 7850 Lörrach Neue aminglykosidderivate, verfahren zu ihrer herstellung und ihre verwendung
US4493831A (en) * 1982-10-25 1985-01-15 Fujisawa Pharmaceutical Co., Ltd. Aminoglycoside derivatives
US6653456B2 (en) 2001-07-31 2003-11-25 Roche Diagnostics Corporation Site-specific aminoglycoside derivatives and their use in immunodiagnostic assays
US7794713B2 (en) * 2004-04-07 2010-09-14 Lpath, Inc. Compositions and methods for the treatment and prevention of hyperproliferative diseases
US20080213274A1 (en) * 2005-10-28 2008-09-04 Sabbadini Roger A Compositions and methods for the treatment and prevention of fibrotic, inflammatory, and neovascularization conditions of the eye
US20090074720A1 (en) * 2005-10-28 2009-03-19 Sabbadini Roger A Methods for decreasing immune response and treating immune conditions
US7862812B2 (en) * 2006-05-31 2011-01-04 Lpath, Inc. Methods for decreasing immune response and treating immune conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4062947A (en) * 1975-11-04 1977-12-13 Schering Corporation Di-N-alkylaminoglycosides, methods for their manufacture and novel intermediates useful therein, method for their use as antibacterial agents and pharmaceutical compositions useful therefor
US4085208A (en) * 1976-06-21 1978-04-18 Schering Corporation Process for preparing 4,6-di-O-(aminoglycosyl)-1,3-diaminocyclitols and novel 1-epimers and 1-N-alkyl derivatives produced thereby; methods for the use of the 1-epimer derivatives as antibacterial agents and compositions useful therefor
DE2737264A1 (de) * 1977-08-18 1979-03-01 Bayer Ag Pseudotrisaccharide

Also Published As

Publication number Publication date
EP0072351B1 (en) 1985-07-24
PT75385A (en) 1982-09-01
AU8678682A (en) 1983-02-10
DK351982A (da) 1983-02-08
ATE14437T1 (de) 1985-08-15
ES8402315A1 (es) 1984-01-16
CA1196629A (en) 1985-11-12
JPS5838299A (ja) 1983-03-05
FI822671A0 (fi) 1982-07-30
ES514767A0 (es) 1984-01-16
DE3264906D1 (en) 1985-08-29
PT75385B (en) 1985-06-28
IL66473A0 (en) 1982-12-31
US4503046A (en) 1985-03-05
ZA825730B (en) 1984-03-28
EP0072351A1 (en) 1983-02-16

Similar Documents

Publication Publication Date Title
YU149791A (sh) Mometason, furoat monohidrat i postupak za njegovo dobijanje
ES8404348A1 (es) Un procedimiento para la preparacion de agentes antifungicos triazolicos.
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
NO308798B1 (no) Proteinkinase-C-hemmere, anvendelse av samme for fremstilling av farmasøytika samt farmasøytisk formulering omfattende samme
ES2134801T3 (es) Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso.
DK0598770T3 (da) Pyrazinderivater samt fremstilling og anvendelse deraf
NO830686L (no) Fremgangsmaate for fremstilling av erytromycinderivater
DK0692484T3 (da) Benzothiadiazinderivat, fremgangsmåde til fremstilling deraf samt farmaceutiske sammensætninger indeholdende derivatet
FI822671L (fi) Aminoglykosidderivat, foerfaranden foer framstaellning av dem, farmaceutiska kompositioner innehaollande dem samt anvaendning av saodana derivat som laekemedel
TR200000153T2 (tr) İl-5 inhibite eden 6-azaurasil türevleri.
DK0634396T3 (da) Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
NO982072D0 (no) Amidin- og isotioureaderivater som inhibitorer av nitrogenoksydsyntase
AU7935887A (en) Therapeutic agent for the treatment of peptic ulcer disease
AU578335B2 (en) N-substituted aziridine-2-carboxylic acid derivatives
KR900014372A (ko) 티에닐피페라진 이의 제조방법 및 이를 함유하는 약제
DK105183D0 (da) Fremgangsmade til fremstilling af 1,4-diaminocyclitolderivater
DK34882A (da) Fremgangsmaade til fremstilling af peptidderivater
IT1245390B (it) Composizione farmaceutica ad attivita' antivirale
GT199700137A (es) Nuevas composiciones farmaceuticas que contienen como principio activo a derivados de n-sulfonil indolina.
IT1255696B (it) Composto con attivita' vasodilatatrice procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: SANDOZ AG